Diagnostics: Page 14
-
FDA authorizes first at-home flu-COVID-19 combination test days after its developer files for bankruptcy
Lucira filed for bankruptcy protection last week, saying the “protracted” authorization process caused it to miss out on test sales in the 2022 to 2023 flu season.
By Nick Paul Taylor • Feb. 27, 2023 -
Q&A
Friday Q&A: GE HealthCare’s Yoder on using AI to drive precision care
The healthcare technology and diagnostics firm, now a standalone company, will integrate the acquisition of AI software developer Caption Health under Yoder’s lead.
By Susan Kelly • Feb. 23, 2023 -
Trendline
Medical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Labcorp expects 2023 revenue growth, helped by Ascension testing agreement
The company’s business model is shifting as the diagnostics firm prepares to spin off its drug development business and expands management of hospital testing labs.
By Elise Reuter • Feb. 16, 2023 -
Baxter, Abbott, Thermo Fisher among medtech firms cutting jobs on supply issues, slide in testing
"What COVID gave to diagnostics companies, COVID taketh away now that the virus is endemic,” said one analyst.
By Susan Kelly • Updated Feb. 13, 2023 -
Illumina posts sales slump in Q4, bets on new sequencing machine to drive 2023 growth
Management is looking to the newly launched NovaSeq X system to help return the company to profitability this year.
By Nick Paul Taylor • Feb. 8, 2023 -
UK health system, under strain, lays out medtech strategy
The state-run National Health Service, now facing a strike by nurses and paramedics, hopes new technologies will help solve some of its long-term challenges to improve patient care.
By Susan Kelly • Feb. 7, 2023 -
Diagnostic firms turn to restructuring in bid to preserve cash: Goldman
The moves could lead to underfunding, delay or cancellation of research and development projects, the analysts say.
By Nick Paul Taylor • Feb. 7, 2023 -
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
Still, the latest round of quarterly results show that hospital staffing and supply chain remain a challenge.
By Nick Paul Taylor • Feb. 6, 2023 -
Quest cuts 2023 COVID tests forecast amid continued slump in demand; Q4 profit plunges
The company performed 1.2 million molecular tests in the fourth quarter, down from 1.9 million in the third quarter and 5.4 million one year ago.
By Nick Paul Taylor • Feb. 3, 2023 -
Q&A
Friday Q&A: Medtronic’s Chan talks patient monitoring spinoff, rise of home care
As more patients are moved out of expensive hospital beds, Medtronic sees a growing market for remote care in homes and long-term care facilities.
By Elise Reuter • Feb. 2, 2023 -
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023 -
Medtech trends in 2023
Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.
By Peter Green • Jan. 31, 2023 -
Researchers create remote-controlled biological robot that could eventually be used in surgery
The design allows the integration of sensors and other components that could eventually equip the robots to detect biomarkers of disease, carry out biopsies or perform surgery.
By Nick Paul Taylor • Jan. 26, 2023 -
Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves
While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.
By Elise Reuter • Jan. 25, 2023 -
FDA weighs shift in COVID vaccination strategy
Agency scientists are proposing to update COVID shots once a year to match circulating coronavirus strains, as well as simplifying current vaccination regimens.
By Ned Pagliarulo • Jan. 23, 2023 -
Q&A
3 questions for Michael Snyder, lead inventor of single-drop blood test
The head of a Stanford research team says the test differs from Theranos' defunct product because "ours works."
By Peter Green • Jan. 23, 2023 -
Stanford team reports progress with Theranos-like finger prick blood test
The researchers have created a system for capturing and analyzing thousands of molecules from a single drop of blood.
By Nick Paul Taylor • Jan. 23, 2023 -
Opinion
Realizing the promise of AI for medical imaging and diagnosis
Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud, explains how medtech companies can benefit from applying AI to the explosion of medical imaging data.
By Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud • Jan. 19, 2023 -
CT scans offer new path to diagnose treatable cause of high blood pressure, study shows
While the approach could increase demand for CT imaging, the supply of radioactive tracers is potentially a barrier to adoption of the technique.
By Nick Paul Taylor • Jan. 19, 2023 -
Deep learning may improve triaging of people with acute chest pain, study shows
The researchers trained a model to find signs in scans that a person may have a serious cardiovascular condition.
By Nick Paul Taylor • Jan. 19, 2023 -
Bayer to buy AI imaging platform Blackford Analysis to bolster radiology growth strategy
Bayer aims to outpace the broader radiology segment by investing in fast-growing technologies such as imaging AI.
By Elise Reuter • Updated Jan. 18, 2023 -
AI predicts lung cancer risk six years into the future using single CT scan: study
A research team has made the deep learning model publicly available and says it has no intention to commercialize it.
By Nick Paul Taylor • Jan. 17, 2023 -
Cue Health lays off 388 people as demand falls for COVID-19 tests
Cue is reducing its headcount by 26% after laying off 170 employees last June.
By Nick Paul Taylor • Jan. 11, 2023 -
Guardant Health posts revenue growth in Q4 on higher clinical testing volumes
The oncology diagnostics company’s preliminary results beat analyst estimates.
By Nick Paul Taylor • Jan. 10, 2023